Regulus Therapeutics
RGLS
#8838
Rank
S$0.15 B
Marketcap
$2.27
Share price
-6.39%
Change (1 day)
-33.28%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$10.45 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are S$10.45 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$10.56 M-16.34%
2023-12-31S$12.62 M-29.82%
2022-12-31S$17.99 M-1.36%
2021-12-31S$18.24 M19.12%
2020-12-31S$15.31 M-48.51%
2019-12-31S$29.74 M-35.54%
2018-12-31S$46.14 M-18.99%
2017-12-31S$56.96 M-11.72%
2016-12-31S$64.52 M168.27%
2015-12-31S$24.05 M-53.87%
2014-12-31S$52.14 M39.01%
2013-12-31S$37.51 M-25.95%
2012-12-31S$50.65 M-53.64%
2011-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$78.30 B 748,632.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$76.92 B 735,425.54%๐Ÿ‡ซ๐Ÿ‡ท France
S$15.24 B 145,703.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$84.98 B 812,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$5.61 B 53,584.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.10 B 914.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$102.54 B 980,409.46%๐Ÿ‡บ๐Ÿ‡ธ USA